Biotechnology

The biotechnology industry focuses on using living organisms and biological systems to develop new products and processes across healthcare, agriculture, industrial processing, and environmental solutions. Its core business involves extensive R&D to translate scientific discoveries into commercialized products addressing global challenges.

The biotechnology industry's performance is driven by technological advancements like AI-driven drug discovery, personalized medicine, gene editing, 3D bioprinting, and synthetic biology. Increasing global demand for advanced healthcare solutions, favorable government initiatives, increasing investments, cross-sector integration, and evolving regulatory adaptation also contribute to the industry's growth.

The biotechnology industry includes over 107,000 companies globally, with over 5,800 startups. Major players include large pharmaceutical companies that collaborate with biotech firms. Companies compete on innovation and intellectual property protection, with the health application segment holding the largest market share.

The biotechnology industry has shown adaptability, growing by 2.50% with strong investment activity. The global market was estimated at USD 1.55 trillion in 2024 and is projected to reach USD 5.71 trillion by 2034, with a CAGR of 13.90%. The outlook for 2025 is cautiously optimistic, driven by innovation in advanced therapies, increased M&A activity, and AI integration.

The biotechnology sector faces risks including complex regulatory landscapes, high product failure rates, financial and funding challenges, intense market competition, ethical controversies, cybersecurity threats, and geopolitical factors.